Trichomoniasis improvement or ways to prevent using natural means by Ray Sahelian, M.D.
April 12 2016

Trichomoniasis is caused by the single-celled parasite Trichomonas vaginalis, It is the most common curable sexually transmitted disease (STD) in the United States. There are an estimated 7 million cases of trich each year in the U.S compared with about 3 million new cases of Chlamydia and 700,000 cases of gonorrhea. Trichomonas infection has been linked to pelvic inflammatory disease, precancerous cervical changes, and premature delivery in women, and may also facilitate the spread of HIV.

Infect Dis Clin North Am. December 2013. Trichomoniasis: the "neglected" sexually transmitted disease. Trichomonas vaginalis is the most prevalent nonviral sexually transmitted infection, affecting an estimated 3.7 million people in the United States. Although trichomoniasis is common, it has been considered a "neglected" sexually transmitted disease, due to limited knowledge of its sequelae and associated costs. This article reviews current epidemiology, pathophysiology, diagnostic methods, clinical management recommendations and special considerations, research on associated conditions and costs, prevention strategies, and controversies regarding trichomoniasis.

Benefit of probiotics
Women appear to have a natural protective barrier against the world's most common sexually transmitted infection due to lactic acid bacteria -- called lactobacilli. Researchers Augusto Simoes-Barbosa, of the University of Auckland in New Zealand examined how easily three different strains of T. vaginalis bound to vaginal cells. They repeated the process when nine different types of lactobacilli were also present. In the vast majority of instances, lactobacilli prevented the parasite from binding to the cells.

Symptoms
Many people with trichomoniasis have no symptoms or only mild symptoms. Signs and symptoms of trichomoniasis in women include itching, redness and a yellow, green or grey vaginal discharge that may be frothy or sticky and have a foul odor. Urination and intercourse may be painful, and the symptoms may worsen during menstruation. When symptoms are present in men, they may consist of urethral discharge and irritation.

Risk of Trichomoniasis
When left untreated, trichomoniasis may enhance both the acquisition and transmission of HIV. The genital inflammation caused by trichomoniasis can increase a woman's susceptibility to HIV infection if she is exposed to the virus. Trichomoniasis also has been shown to increase the risk of infertility in women and may play a role in promoting cervical cancer and pelvic inflammatory disease. In a large Finnish study, trich was associated with a six-fold increased risk of cervical cancer in women compared with those who were uninfected. The STD has also been linked to preterm birth and postoperative infection in women, and lower sperm motility and nongonococcal urethritis in men.

Trichomoniasis in a man
Nearly three-quarters of the male sexual partners of women with the common sexually transmitted disease trichomoniasis carry the infection themselves, but the vast majority has no symptoms. Thus it is important to include men in efforts to control the spread of trichomoniasis.

Diagnosis of trichomoniasis
Lab tests commonly used to detect the infection can only typically identify people carrying large amounts of the organism. Therefore, some infections -- especially those that don't cause symptoms -- may be missed.

New Trichomoniasis Treatment
Mission Pharmacal has an antiprotozoal drug Tindamax (tinidazole) as a first line therapy for the treatment of trichomoniasis. Tindamax, which is administered orally and taken as a single 2-gram dose, has demonstrated cure rates of more than 90 percent.

About Tindamax
Tindamax, a second-generation 5-nitroimidazole compound, is indicated in the United States for the treatment of trichomoniasis, the intestinal infections giardiasis and intestinal amebiasis, and amebic liver abscess. It has been approved for use in the United States since 2004 and is recommended as one of the drugs of choice for the treatment of trichomoniasis by the Centers for Disease Control and Prevention.

Parasitol Res. Feb 2 2014. The antitrichomonal efficacy of garlic and metronidazole against Trichomonas gallinae infecting domestic pigeons. Our results indicated that garlic may be a promising phytotherapeutic agent for protection against trichomoniasis in pigeons.

Sexually transmitted diseases, which are increasing, which decreasing?
Sexually transmitted infections (STIs) remain a significant burden on public health in the United States. Primary prevention counseling with early diagnosis and treatment remain the best methods to decrease the incidence of STIs. Through significant public heath interventions, the incidence of gonorrhea, Chlamydia, and trichomoniasis is decreasing; however, the incidence of primary and secondary syphilis is increasing. Human papilloma virus remains the most common STI, but new vaccinations have the possibility of having a significant impact on this virus's disease potential.